NEVVI Medicare utilization intelligence
or

← back

Provider profile

HAWKINS, JOSEPH M.D.

Endocrinology · NPI 1841296894 · FRESNO, CA

1
Groups
18
Codes · 2024
71,476
Disclosed services

HAWKINS, JOSEPH is a Endocrinology in FRESNO, CA, a member of 1 medical group, who billed 18 distinct codes to Medicare Part B in 2024.

Groups: COMMUNITY HEALTH PARTNERS (FRESNO, CA)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

71,476
disclosed services
18
codes billed to Medicare Part B
Prior year · CY2023 88,711 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
77085 Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment
77089 Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk
96372 Injection of drug or substance under skin or into muscle
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J3489 Injection, zoledronic acid, 1 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
82948 Blood glucose (sugar) measurement using reagent strip
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
82962 Blood glucose (sugar) test performed by hand-held instrument
95249 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.